Brand Name | Status | Last Update |
---|---|---|
aminosyn ii | New Drug Application | 2022-05-04 |
aminosyn-pf | New Drug Application | 2022-07-21 |
clinisol | ANDA | 2018-06-01 |
kabiven | New Drug Application | 2023-08-02 |
perikabiven | New Drug Application | 2023-08-07 |
plenamine | ANDA | 2023-04-21 |
premasol - sulfite-free (amino acid) | ANDA | 2022-08-04 |
prosol | New Drug Application | 2020-10-07 |
trophamine | New Drug Application | 2022-08-22 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Major depressive disorder | D003865 | EFO_0003761 | F22 | 6 | 6 | 3 | 1 | 12 | 28 |
Depression | D003863 | — | F33.9 | 6 | 6 | 3 | 2 | 5 | 21 |
Schizophrenia | D012559 | EFO_0000692 | F20 | 3 | 5 | 3 | 4 | 3 | 18 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | 2 | 4 | 1 | 2 | 5 | 14 |
Alcoholism | D000437 | EFO_0003829 | F10.1 | 3 | 3 | — | 2 | 3 | 11 |
Parkinson disease | D010300 | EFO_0002508 | G20 | 2 | 7 | — | 1 | 1 | 9 |
Psychotic disorders | D011618 | — | F20.81 | 1 | 1 | — | 2 | 2 | 6 |
Cocaine-related disorders | D019970 | — | F14 | 2 | 1 | — | 1 | 1 | 5 |
Brain neoplasms | D001932 | EFO_0003833 | C71 | — | — | — | 1 | 2 | 3 |
Anxiety | D001007 | EFO_0005230 | F41.1 | — | — | — | 2 | — | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Non-small-cell lung carcinoma | D002289 | — | — | 3 | 14 | 6 | — | 1 | 22 |
Healthy volunteers/patients | — | — | — | 13 | 5 | 1 | — | 4 | 21 |
Lung neoplasms | D008175 | HP_0100526 | C34.90 | 1 | 6 | 3 | — | 1 | 10 |
Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | 6 | 2 | — | 1 | 9 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 3 | 3 | 1 | — | — | 6 |
Treatment-resistant depressive disorder | D061218 | — | — | 3 | 2 | 1 | — | — | 6 |
Epilepsy | D004827 | EFO_0000474 | G40.9 | 1 | 1 | 1 | — | 4 | 6 |
Attention deficit disorder with hyperactivity | D001289 | EFO_0003888 | F90 | 1 | 2 | 1 | — | 2 | 5 |
Malignant mesothelioma | D000086002 | — | — | 3 | 2 | 1 | — | — | 4 |
Fallopian tube neoplasms | D005185 | — | — | 2 | 1 | 1 | — | — | 4 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obsessive-compulsive disorder | D009771 | EFO_0004242 | F42 | 1 | 8 | — | — | 3 | 11 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 6 | 7 | — | — | — | 8 |
Triple negative breast neoplasms | D064726 | — | — | 2 | 4 | — | — | — | 4 |
Traumatic brain injuries | D000070642 | — | S06 | 3 | 1 | — | — | — | 4 |
Stroke | D020521 | EFO_0000712 | I63.9 | — | 2 | — | — | 2 | 4 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | 1 | 1 | — | — | 2 | 4 |
Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | 1 | 3 |
Adenocarcinoma of lung | D000077192 | — | — | 1 | 1 | — | — | 1 | 3 |
Autistic disorder | D001321 | HP_0000717 | F84.0 | 1 | 1 | — | — | 1 | 3 |
Autism spectrum disorder | D000067877 | HP_0000729 | F84.0 | 1 | 1 | — | — | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | 1 | — | — | — | 2 | 3 |
Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | 1 | 2 |
Hepatocellular carcinoma | D006528 | — | C22.0 | 1 | — | — | — | 1 | 2 |
Positron-emission tomography | D049268 | — | — | 1 | — | — | — | 1 | 2 |
Pharmacokinetics | D010599 | — | — | 2 | — | — | — | — | 2 |
Severe acute respiratory syndrome-related coronavirus | D045473 | NCBITaxon_227859 | — | 2 | — | — | — | — | 2 |
Cigarette smoking | D000073865 | — | — | 1 | — | — | — | 1 | 2 |
Consciousness disorders | D003244 | — | — | 1 | — | — | — | — | 1 |
Osteosarcoma | D012516 | — | — | 1 | — | — | — | — | 1 |
Cystadenocarcinoma | D003536 | — | — | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Burns | D002056 | — | T30.0 | — | — | — | — | 5 | 5 |
Pain | D010146 | EFO_0003843 | R52 | — | — | — | — | 2 | 2 |
Nervous system diseases | D009422 | — | G00-G99 | — | — | — | — | 2 | 2 |
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | — | — | — | — | 2 | 2 |
Irritable bowel syndrome | D043183 | EFO_0000555 | K58 | — | — | — | — | 2 | 2 |
Systemic lupus erythematosus | D008180 | HP_0002725 | M32 | — | — | — | — | 2 | 2 |
Amyotrophic lateral sclerosis | D000690 | HP_0007354 | G12.21 | — | — | — | — | 2 | 2 |
Restless legs syndrome | D012148 | EFO_0004270 | G25.81 | — | — | — | — | 2 | 2 |
Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | — | — | — | 1 | 1 |
Hemolysis | D006461 | — | — | — | — | — | — | 1 | 1 |
Drug common name | D-glutamate |
INN | — |
Description | D-glutamic acid is an optically active form of glutamic acid having D-configuration. It has a role as an Escherichia coli metabolite and a mouse metabolite. It is a D-alpha-amino acid and a glutamic acid. It is a conjugate acid of a D-glutamate(1-). It is an enantiomer of a L-glutamic acid. |
Classification | Small molecule |
Drug class | — |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | N[C@H](CCC(=O)O)C(=O)O |
PDB | — |
CAS-ID | 6893-26-1 |
RxCUI | — |
ChEMBL ID | CHEMBL76232 |
ChEBI ID | 15966 |
PubChem CID | 23327 |
DrugBank | DB02517 |
UNII ID | — |